前列腺癌
雄激素受体
小干扰RNA
化学
癌症研究
前列腺
癌症
转染
生物
生物化学
内科学
医学
基因
作者
Justin B. Lee,Kaixin Zhang,Yuen Yi C. Tam,Joslyn Quick,Ying K. Tam,Paulo J.C. Lin,Sam Chen,Yan Liu,Jayaprakash K. Nair,Ivan Zlatev,Kallanthottathil G. Rajeev,Muthiah Manoharan,Paul S. Rennie,Pieter R. Cullis
摘要
The androgen receptor plays a critical role in the progression of prostate cancer. Here, we describe targeting the prostate-specific membrane antigen using a lipid nanoparticle formulation containing small interfering RNA designed to silence expression of the messenger RNA encoding the androgen receptor. Specifically, a Glu-urea-Lys PSMA-targeting ligand was incorporated into the lipid nanoparticle system formulated with a long alkyl chain polyethylene glycol-lipid to enhance accumulation at tumor sites and facilitate intracellular uptake into tumor cells following systemic administration. Through these features, and by using a structurally refined cationic lipid and an optimized small interfering RNA payload, a lipid nanoparticle system with improved potency and significant therapeutic potential against prostate cancer and potentially other solid tumors was developed. Decreases in serum prostate-specific antigen, tumor cellular proliferation, and androgen receptor levels were observed in a mouse xenograft model following intravenous injection. These results support the potential clinical utility of a prostate-specific membrane antigen-targeted lipid nanoparticle system to silence the androgen receptor in advanced prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI